Connect with us

Technology

Lam Research Corporation Reports Financial Results for the Quarter Ended March 29, 2026

Published

on

FREMONT, Calif., April 22, 2026 /PRNewswire/ — Lam Research Corporation (the “Company,” “Lam,” “Lam Research”) today announced financial results for the quarter ended March 29, 2026 (the “March 2026 quarter”).

Highlights for the March 2026 quarter were as follows:

Revenue of $5.84 billion.U.S. GAAP gross margin as a percent of revenue of 49.8%, U.S. GAAP operating margin as a percent of revenue of 35.0%, and U.S. GAAP diluted EPS of $1.45.Non-GAAP gross margin as a percent of revenue of 49.9%, non-GAAP operating margin as a percent of revenue of 35.0%, and non-GAAP diluted EPS of $1.47.

Key Financial Data for the Quarters Ended

March 29, 2026 and December 28, 2025

(in thousands, except per-share data, percentages, and basis points) 

U.S. GAAP

March 2026

December 2025

Change Q/Q

Revenue

$          5,841,488

$          5,344,791

+9 %

Gross margin

49.8 %

49.6 %

+ 20 bps

Operating margin

35.0 %

33.9 %

+ 110 bps

Diluted EPS

$                   1.45

$                   1.26

+ 15 %

Non-GAAP

March 2026

December 2025

Change Q/Q

Revenue

$          5,841,488

$          5,344,791

+9 %

Gross margin

49.9 %

49.7 %

+ 20 bps

Operating margin

35.0 %

34.3 %

+ 70 bps

Diluted EPS

$                   1.47

$                   1.27

+ 16 %

U.S. GAAP Financial Results

For the March 2026 quarter, revenue was $5,841 million, gross margin was $2,911 million, or 49.8% of revenue, operating expenses were $864 million, operating margin was 35.0%, and net income was $1,825 million, or $1.45 per diluted share on a U.S. GAAP basis. This compares to revenue of $5,345 million, gross margin of $2,651 million, or 49.6% of revenue, operating expenses of $841 million, operating margin of 33.9%, and net income of $1,594 million, or $1.26 per diluted share, for the quarter ended December 28, 2025 (the “December 2025 quarter”).

Non-GAAP Financial Results

For the March 2026 quarter, non-GAAP gross margin was $2,913 million, or 49.9% of revenue, non-GAAP operating expenses were $866 million, non-GAAP operating margin was 35.0%, and non-GAAP net income was $1,851 million, or $1.47 per diluted share. This compares to non-GAAP gross margin of $2,658 million, or 49.7% of revenue, non-GAAP operating expenses of $827 million, non-GAAP operating margin of 34.3%, and non-GAAP net income of $1,598 million, or $1.27 per diluted share, for the December 2025 quarter.

“Lam delivered record revenue and EPS in the March quarter as AI-driven demand reshapes the semiconductor industry,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “Our strategic investments and the velocity of our execution are generating strong momentum, enabling customers’ AI roadmaps and driving Lam’s outperformance during this critical phase of industry growth.”

Balance Sheet and Cash Flow Results

Cash, cash equivalents, and restricted cash balances decreased to $4.77 billion at the end of the March 2026 quarter compared to $6.20 billion at the end of the December 2025 quarter. The decrease was primarily the result of cash deployed for capital return activities, principal payment on debt instruments, and capital expenditures, partially offset by cash generated from operating activities during the quarter.

Deferred revenue at the end of the March 2026 quarter decreased slightly to $2.22 billion compared to $2.25 billion as of the end of the December 2025 quarter. Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom control does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $434 million as of March 29, 2026 and $226 million as of December 28, 2025.

Revenue

The geographic distribution of revenue during the March 2026 quarter is shown in the following table:

Region

Revenue

China

34 %

Korea

23 %

Taiwan

23 %

Japan

8 %

United States

6 %

Southeast Asia                                                                                                                                                                     

4 %

Europe

2 %

The following table presents revenue disaggregated between systems and customer support-related revenue:

Three Months Ended

March 29,
2026

December 28,
2025

March 30,
2025

(In thousands)

Systems revenue

$         3,730,582

$         3,357,493

$         3,035,276

Customer support-related revenue and other                                                

2,110,906

1,987,298

1,684,899

$         5,841,488

$         5,344,791

$         4,720,175

Systems revenue includes sales of new leading-edge equipment in deposition, etch, and other wafer fabrication markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.

Outlook

For the quarter ending June 28, 2026, Lam is providing the following guidance:

U.S. GAAP

Reconciling Items

Non-GAAP

Revenue

$6.60 Billion

+/-

$400 Million

$6.60 Billion

+/-

$400 Million

Gross margin

50.5 %

+/-

1 %

$  2.7

Million

50.5 %

+/-

1 %

Operating margin

36.5 %

+/-

1 %

$  3.0

Million

36.5 %

+/-

1 %

Net income per diluted share               

$1.65

+/-

$0.15

$  3.3

Million

$1.65

+/-

$0.15

Diluted share count

1.255 Billion

1.255 Billion

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

Gross margin – amortization related to intangible assets acquired through business combinations, $2.7 million.Operating margin – amortization related to intangible assets acquired through business combinations, $3.0 million.Net income per diluted share – amortization related to intangible assets acquired though business combinations, $3.0 million; amortization of debt discounts, $0.5 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.3 million.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the March 2026 and December 2025 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax effect of non-GAAP items. In addition, the March 2026 quarter excludes expenses associated with workforce optimization activities and their associated income tax effect.

Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating margin, net income per diluted share, and diluted share count; the extent to which our investments and rate of operational execution are enabling our customers, driving our performance and generating momentum; and customer and industry trends, including the role of AI as an industry driver. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our most recent annual report on Form 10-K or subsequent quarterly report on Form 10-Q. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)

Consolidated Financial Tables Follow.

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited) 

Three Months Ended

Nine Months Ended

March 29,
2026

December 28,
2025

March 30,
2025

March 29,
2026

March 30,
2025

Revenue

$  5,841,488

$  5,344,791

$  4,720,175

$ 16,510,452

$ 13,264,198

Cost of goods sold

2,930,961

2,693,629

2,406,489

8,263,884

6,874,848

Gross margin

2,910,527

2,651,162

2,313,686

8,246,568

6,389,350

Gross margin as a percent of revenue

49.8 %

49.6 %

49.0 %

49.9 %

48.2 %

Research and development

583,200

573,305

525,904

1,732,951

1,516,209

Selling, general and administrative

280,311

267,654

226,023

827,310

713,301

Total operating expenses

863,511

840,959

751,927

2,560,261

2,229,510

Operating income

2,047,016

1,810,203

1,561,759

5,686,307

4,159,840

Operating margin

35.0 %

33.9 %

33.1 %

34.4 %

31.4 %

Other income (expense), net

(35,460)

26,410

(25,035)

21,024

19,308

Income before income taxes

2,011,556

1,836,613

1,536,724

5,707,331

4,179,148

Income tax expense

(186,096)

(242,619)

(206,057)

(719,217)

(541,019)

Net income

$  1,825,460

$  1,593,994

$  1,330,667

$  4,988,114

$ 3,638,129

Net income per share:

Basic

$           1.46

$           1.27

$           1.04

$           3.97

$          2.82

Diluted

$           1.45

$           1.26

$           1.03

$           3.95

$          2.81

Number of shares used in per share calculations:

Basic

1,249,728

1,254,856

1,283,779

1,256,343

1,290,041

Diluted

1,257,325

1,261,739

1,288,100

1,262,792

1,294,545

Cash dividend declared per common share

$           0.26

$           0.26

$           0.23

$           0.78

$          0.69

 

 LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

March 29,
2026

December 28,
2025

June 29,
2025

(unaudited)

(unaudited)

(1)

ASSETS

Cash and cash equivalents

$      4,750,936

$      6,180,440

$      6,390,659

Accounts receivable, net

4,132,890

3,491,987

3,378,071

Inventories

3,999,992

4,037,682

4,307,991

Prepaid expenses and other current assets

413,099

307,914

440,274

Total current assets

13,296,917

14,018,023

14,516,995

Property and equipment, net

2,853,614

2,710,989

2,428,744

Goodwill and intangible assets

1,882,017

1,864,037

1,808,685

Other assets

2,759,362

2,798,122

2,590,836

Total assets

$    20,791,910

$    21,391,171

$    21,345,260

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current portion of long-term debt and finance lease obligations                                        

$             4,095

$         754,006

$         754,311

Other current liabilities

5,238,303

5,459,147

5,814,114

Total current liabilities

5,242,398

6,213,153

6,568,425

Long-term debt and finance lease obligations

3,730,384

3,729,742

3,730,194

Income taxes payable

621,572

667,639

603,412

Other long-term liabilities

612,777

635,211

581,610

Total liabilities

10,207,131

11,245,745

11,483,641

Stockholders’ equity (2)

10,584,779

10,145,426

9,861,619

Total liabilities and stockholders’ equity

$    20,791,910

$    21,391,171

$    21,345,260

(1)

Derived from audited financial statements.

(2)

Common shares issued and outstanding were 1,250,539 as of March 29, 2026, 1,251,180 as of December 28, 2025, and
1,268,740 as of June 29, 2025.

 

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands, unaudited)

Three Months Ended

Nine Months Ended

March 29,
2026

December 28,
2025

March 30,
2025

March 29,
2026

March 30,
2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

$      1,825,460

$      1,593,994

$      1,330,667

$      4,988,114

$      3,638,129

Adjustments to reconcile net income to net cash provided

by operating activities:

Depreciation and amortization

116,322

103,925

97,343

321,891

287,838

Deferred income taxes

(19,478)

(30,957)

(19,992)

(113,310)

(211,568)

Equity-based compensation expense

96,616

88,539

87,115

282,396

249,085

Other, net

(2,855)

(19,961)

1,654

(24,706)

(7,395)

Changes in operating assets and liabilities

(874,645)

(255,495)

(188,124)

(1,053,956)

(337,013)

Net cash provided by operating activities

1,141,420

1,480,045

1,308,663

4,400,429

3,619,076

CASH FLOWS FROM INVESTING ACTIVITIES:

Capital expenditures and intangible assets

(331,604)

(260,879)

(288,058)

(777,604)

(586,995)

Other, net

(2,976)

3,096

(4,857)

(807)

8,154

Net cash used for investing activities

(334,580)

(257,783)

(292,915)

(778,411)

(578,841)

CASH FLOWS FROM FINANCING ACTIVITIES:

Principal payments on debt, including finance lease

obligations and payments for debt issuance costs

(751,194)

(1,462)

(504,037)

(754,073)

(506,003)

Treasury stock purchases, including excise tax payments

(1,162,837)

(1,466,155)

(435,321)

(3,604,783)

(2,130,044)

Dividends paid

(325,829)

(327,507)

(295,716)

(945,317)

(854,335)

Reissuance of treasury stock related to employee stock

purchase plan

67,185

67,185

60,557

Proceeds from issuance of common stock, net issuance

 costs

9,167

3,854

1,993

13,021

1,756

Other, net

55

(1,117)

526

(13,511)

963

Net cash used for financing activities

(2,230,638)

(1,725,202)

(1,232,555)

(5,237,478)

(3,427,106)

Effect of exchange rate changes on cash, cash equivalents,

and restricted cash

(4,979)

(13,337)

2,380

(25,375)

(960)

Net change in cash, cash equivalents, and restricted cash

(1,428,777)

(516,277)

(214,427)

(1,640,835)

(387,831)

Cash, cash equivalents, and restricted cash at beginning of

period (1)

6,195,598

6,711,875

5,677,399

6,407,656

5,850,803

Cash, cash equivalents, and restricted cash at end of

period (1)

$      4,766,821

$      6,195,598

$      5,462,972

$      4,766,821

$      5,462,972

(1)

Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets

 

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)

Three Months Ended

March 29,
2026

December 28,
2025

Revenue

$     5,841,488

$     5,344,791

Gross margin

$     2,913,123

$     2,658,256

Gross margin as a percent of revenue

49.9 %

49.7 %

Operating expenses

$        866,166

$        827,486

Operating income

$     2,046,957

$     1,830,770

Operating margin

35.0 %

34.3 %

Net income

$     1,851,442

$     1,597,626

Net income per diluted share

$              1.47

$              1.27

Shares used in per share calculation – diluted                                                                                                              

1,257,325

1,261,739

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(in thousands, except per share data)

(unaudited) 

Three Months Ended

March 29,
2026

December 28,
2025

U.S. GAAP net income

$       1,825,460

$       1,593,994

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations – cost of goods sold     

2,668

2,668

Elective deferred compensation (“EDC”) related liability valuation (decrease) increase – cost of goods sold

(6,476)

4,426

Workforce optimization charges – cost of goods sold

6,404

EDC related liability valuation (decrease) increase – research and development

(11,656)

7,968

Workforce optimization charges – research and development

9,437

Amortization related to intangible assets acquired through certain business combinations – selling, general

and administrative

348

193

EDC related liability valuation (decrease) increase – selling, general and administrative

(7,771)

5,312

Workforce optimization charges – selling, general and administrative

6,987

Amortization of note discounts – other income (expense), net

674

701

Loss (gain) on EDC related asset – other income (expense), net

27,265

(16,628)

Net income tax benefit on non-GAAP items

(1,898)

(1,008)

Non-GAAP net income

$       1,851,442

$       1,597,626

Non-GAAP net income per diluted share

$                1.47

$                1.27

U.S. GAAP net income per diluted share

$                1.45

$                1.26

U.S. GAAP and non-GAAP number of shares used for per diluted share calculation

1,257,325

1,261,739

 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,

Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited) 

Three Months Ended

March 29,
2026

December 28,
2025

U.S. GAAP gross margin

$     2,910,527

$     2,651,162

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations                                   

2,668

2,668

EDC related liability valuation (decrease) increase

(6,476)

4,426

Workforce optimization charges

6,404

Non-GAAP gross margin

$     2,913,123

$     2,658,256

U.S. GAAP gross margin as a percent of revenue

49.8 %

49.6 %

Non-GAAP gross margin as a percent of revenue

49.9 %

49.7 %

U.S. GAAP operating expenses

$        863,511

$        840,959

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired through certain business combinations

(348)

(193)

EDC related liability valuation decrease (increase)

19,427

(13,280)

Workforce optimization charges

(16,424)

Non-GAAP operating expenses

$        866,166

$        827,486

U.S. GAAP operating income

$     2,047,016

$     1,810,203

Non-GAAP operating income

$     2,046,957

$     1,830,770

U.S. GAAP operating margin

35.0 %

33.9 %

Non-GAAP operating margin

35.0 %

34.3 %

Lam Research Corporation Contacts:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lam-research-corporation-reports-financial-results-for-the-quarter-ended-march-29-2026-302750629.html

SOURCE Lam Research Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

Published

on

By

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ — MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest advancements in sequencing, automation and clinical genomics at the European Society of Human Genetics (ESHG) 2026 Conference in Gothenburg, Sweden.

At Booth 352, MGI welcomes researchers, clinicians, laboratory leaders and industry partners to explore its comprehensive portfolio of sequencing and automation solutions while unveiling new initiatives designed to strengthen collaboration across the genomics ecosystem.

Advancing Clinical Genomics Through Partnership

A key highlight of ESHG 2026 is the launch of the MGI NGS Partner Enablement Program, a new initiative designed to connect diagnostic developers, assay providers and laboratory partners seeking to build validated clinical workflows on MGI sequencing platforms.

The program aims to accelerate the development and adoption of regulated next-generation sequencing (NGS) applications by fostering collaborations that simplify workflow implementation, reduce time-to-market and support broader access to precision medicine solutions.

“Clinical genomics is increasingly dependent on strong partnerships across the value chain,” said Fang Chen, General Manager Europe & Africa at MGI. “With the launch of our NGS Partner Enablement Program, we are creating a collaborative framework that brings together assay developers, software providers, automation partners and clinical laboratories to accelerate access to high-quality genomic testing.”

Expanding Automation Capabilities Through OEM Collaborations

At ESHG 2026, MGI is also announcing new Original Equipment Manufacturer (OEM) partnership opportunities on MGI’s DE Bundles (integrated library preparation and sequencing platform), bringing turnkey automation to global partners. The DE Bundle includes the current D4+E25 combination, as well as the new D16 paired with the E25 featuring a new 50M flow cell.

The D16, which will be launched later this year, is a benchtop, mid-to-low throughput library prep system and the upgraded successor to the D4. Retaining the fully enclosed contamination control system, it integrates a single-channel robotic pipetting module to maximize automation. With two sample preparation cartridges each processing 8 samples, the D16 delivers significantly higher throughput. The D16 and E25 systems provide flexible and scalable automation solutions for library construction, sequencing, bioinformatics analysis, streamlining the entire laboratory workflow.

Through this open OEM framework, MGI is enabling customers and solution providers to integrate proven automation technologies into customized workflows tailored to specific clinical and research applications. The OEM program reflects MGI’s commitment to building an open ecosystem that empowers laboratories to increase efficiency, improve standardization and accelerate scientific discovery.

“We are excited to expand the opportunities available to our OEM partners by providing access to the D16 platform, enabling the development of truly walkaway solutions that simplify and automate complex laboratory workflows,” said Wim Vervaeke, OEM Director at Europe & Africa at MGI. “Our innovations, including the PrepALL, E25, and G99, have already sparked new partnerships across the life sciences ecosystem. By combining MGI’s automation expertise with the specialized capabilities of our partners, we are creating integrated solutions that deliver maximum value, efficiency, and convenience for end users.”

Corporate Satellite Symposium Highlights Clinical Genomics, Precision Oncology and Spatial Multi-Omics

As part of ESHG 2026, MGI hosted its Corporate Satellite Symposium, Advancing Diagnostics: From Clinical Implementation to Biomarker Discovery, bringing together leading experts from across Europe to showcase how advanced genomic technologies are being translated into real-world clinical and research impact. The symposium highlighted applications spanning clinical oncology diagnostics, pharmacogenomics, and spatial multi-omics.

Dr. Raquel T. Lima from IPATIMUP (Portugal) presented the clinical value of RNA sequencing for detecting actionable gene fusions in solid tumours, improving diagnostic yield and supporting precision oncology decision-making. Prof. Dr. Andreas Braun from University Hospital Schleswig-Holstein (Germany) shared how spatial biology technologies map the tumour microenvironment in melanoma, revealing tumour heterogeneity, cellular interactions, and mechanisms associated with disease progression and treatment response. Dr. Andrea Conti from BMR Genomics (Italy) explored the opportunities of whole genome sequencing for pharmacogenetic marker evaluation, highlighting how comprehensive genomic approaches can support the implementation of personalised medicine through improved identification of clinically relevant variants.

Together, the presentations demonstrated how genomic and multi-omics technologies are advancing clinical diagnostics, translational oncology research, and precision medicine, while highlighting the growing role of sequencing in delivering actionable insights across healthcare and biomedical research.

Comprehensive Solutions for Genomics and Multi-Omics Research

Visitors to the MGI booth can explore the company’s comprehensive portfolio of sequencing and automation technologies supporting applications across human genetics, oncology, reproductive health, population genomics and multi-omics research.

Highlighting strong market adoption, MGI is showcasing the T7+, its ultra-high-throughput sequencing platform at the conference. Following its official launch for the Europe and Africa region at Analytica 2026 in Munich, the T7+ has gained significant momentum, with 27 units installed worldwide as of the end of 2025. From benchtop to ultra-high-throughput sequencing platforms, as well as advanced laboratory automation solutions, MGI continues to support laboratories seeking high-performance, scalable and cost-effective genomics workflows.

“Our mission extends beyond delivering innovative technologies,” said Dr. Christian Zimmerman, VP Sales Europe & Africa at MGI. “We are focused on building a complete ecosystem that enables our customers to transition seamlessly from research to clinical implementation. The partnerships and initiatives we are launching at ESHG 2026 demonstrate our commitment to making genomic technologies more accessible, integrated and impactful.”

Driving the Future of Precision Medicine in Europe

Europe remains a strategic region for MGI, with growing adoption of genomic technologies across research institutions, healthcare systems and national population initiatives.

Through continued investment in sequencing innovation, automation, clinical partnerships and collaborative ecosystem development, MGI is helping accelerate the transition toward more precise, data-driven healthcare.

As genomics increasingly becomes integrated into routine clinical practice, MGI remains committed to providing the technologies and partnerships necessary to support the next generation of precision medicine.

About MGI

MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries.

Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. As one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers, MGI empowers global users with scalable sequencing capabilities ranging from Gb to Tb levels. MGI also stands out as one of the only providers of a full-stack product portfolio that spans three core segments: SEQ ALL (short- and long-read sequencing), GLI (Generative Lab Intelligence), and Multi-Omics. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.

To learn more, please visit MGI TechLinkedInX, Instagram, and YouTube.

 

View original content:https://www.prnewswire.co.uk/news-releases/mgi-tech-showcases-expanding-genomics-ecosystem-at-eshg-2026-with-new-ivd-partnering-program-and-oem-collaborations-302799622.html

Continue Reading

Technology

VEVOR Launches “Beat the Heat at Home” Summer Comfort Lineup for Outdoor Living

Published

on

By

HOUSTON, June 13, 2026 /PRNewswire/ — As summer temperatures climb, staying cool at home shouldn’t require a sky-high electric bill, a cooler full of gas-station ice, or a contractor booked out until September. A smarter approach is gaining traction among American families: investing in the right tools to make outdoor living genuinely comfortable without the premium price tag. VEVOR — a trusted home improvement brand serving over 30 million home creators worldwide — today launches “Beat the Heat at Home,” a summer comfort lineup featuring shade, ice-making, and airflow solutions that deliver pro-level performance so your backyard truly becomes the place to be this summer.

“Summer comfort is not only about staying cool — it is about making outdoor spaces easier to enjoy,” said Gavin Wu, Brand Director at VEVOR. “With this lineup, VEVOR brings pro-level performance into practical home scenarios, helping Home Creators upgrade their backyards, patios, garages, and hosting spaces at exceptional value.”

Cool Living, Cold Drinks, Total Comfort
For most families, a truly comfortable summer day comes down to three things: a shady spot, a steady supply of ice-cold drinks, and enough airflow to keep the evening from feeling stagnant. Traditional solutions — pergolas, commercial ice machines, wired-in fans — often cost thousands or require contractors.

To bridge this gap, VEVOR’s Annual Big Summer Sale officially introduces the “Beat the Heat” collection. Together, the lineup addresses three common summer comfort needs: shade, ice, and airflow, so every corner of the backyard is covered. By delivering pro-level performance in effortless, budget-friendly setups, VEVOR offers Home Creators the ultimate plug-and-play summer cooling experience, making premium seasonal comfort accessible right out of the box.

Create Shade in Minutes
There’s a specific moment every summer host knows too well: the sun shifts, the one shady corner disappears, and suddenly everyone is squinting, relocating chairs, or retreating indoors altogether. It’s the kind of small frustration that quietly ruins an otherwise perfect afternoon.

VEVOR’s Pop-Up Canopy Gazebo was designed for exactly that moment. Available in 10×10, 11.5×11.5, and 12×12 ft configurations, it turns any open stretch of lawn or driveway into a comfortable, shaded gathering space — and it does so in minutes — designed for tool-free setup from the start. The mesh sidewalls earn their keep once evening arrives: mosquitoes stay out while the breeze still flows through, which means dinner can linger as long as the conversation does.

It’s not a permanent structure, and that’s the point. When the season changes or the party moves, the canopy folds back down just as quickly. For homeowners who want shade on their terms, not on a contractor’s timeline, it offers a flexible alternative to permanent shade structures.

Never Run Out of Ice
Few things signal “this gathering is winding down” faster than reaching into a cooler and finding nothing but lukewarm water and half-melted slush. Bags of store-bought ice solve the problem temporarily, but anyone who has made two mid-party runs to the gas station knows the drill gets old fast.

VEVOR’s Commercial Ice Maker Machine helps home hosts keep up with high-demand summer gatherings. Producing up to 130 lbs of ice every 24 hours and holding 33 lbs in its built-in storage bin, it keeps pace with a full afternoon of refills — lemonade pitchers, cocktail shakers, coolers for the kids’ juice boxes, all of it. The stainless-steel build looks at home in a garage bar or outdoor kitchen, and one-touch self-cleaning means maintenance is measured in button presses, not scrub sessions.

Keep the Air Moving
Anyone who has spent a July evening on a covered porch knows the paradox: the roof blocks the sun, but it also traps every degree of rising heat with nowhere to go. The air sits heavy, the ceiling feels lower than it is, and even a beautiful outdoor space starts to feel like something you’d rather admire from behind a glass door with the AC running inside.

VEVOR’s 18-Inch Wall-Mount Fan was built for exactly these in-between spaces that central air can’t reach and a tabletop fan can’t handle. Three-speed settings push up to 4,150 CFM of airflow across patios, enclosed porches, workshops, and garage gyms. That’s the kind of serious air movement that makes a covered space feel open again. With ETL certification and weather-resistant construction, it is designed for covered or semi-outdoor spaces where moisture and humidity are common.

Mounted on the wall and out of the way, it doesn’t eat into floor space or crowd a table. For households looking to cut back on running central AC in every room all day, a well-placed fan in the spaces where the family actually gathers is often the simplest and most cost-effective first step.

The deals are live — don’t leave them on the table.

Cool your summer now: vevor.com/summer-cooling

Shop VEVOR’s Summer Sale: vevor.com/summer-sale

Visit in person: VEVOR Houston Store: 10951 Farm to Market 1960 Road W, Houston

Summer won’t wait. Neither should your backyard. More deals, more summer-ready upgrades — all waiting for you.

About VEVOR
Pro-Level Performance Without the Pro-Level Price. VEVOR is a home improvement brand built for Home Creators who want to upgrade their spaces with practical, high-performing products at exceptional value. From outdoor living and tools to home improvement equipment and everyday project essentials, VEVOR helps people take on upgrades with confidence, efficiency, and value.

Today, VEVOR operates in over 50 countries, supported by a network of 200+ global warehouses and a catalog of more than 15,000 SKUs spanning tools, outdoor equipment, and home improvement solutions. VEVOR has supported over 30 million Home Creators worldwide, bringing performance, inspiration, and value to their home improvement projects. For more information, visit www.vevor.com. VEVOR products are also available on Amazon.

Media Contact
VEVOR Communications Team
media@vevor.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vevor-launches-beat-the-heat-at-home-summer-comfort-lineup-for-outdoor-living-302797877.html

SOURCE VEVOR

Continue Reading

Technology

YEEDI Delivers Lowest-Ever Pricing on Self-Cleaning Roller Mop Robot Vacuums With Early Prime Day Deals

Published

on

By

Starting June 13, M14 PLUS and S14 PLUS Drop to $399.99, Bringing Advanced Self-Cleaning Roller Mop Technology Into the Sub-$400 Segment

SAN FRANCISCO, June 13, 2026 /PRNewswire/ — YEEDI, a home cleaning technology brand focused on practical innovation and high-performance smart home solutions, is kicking off Prime Day early by offering its M14 PLUS and S14 PLUS at their lowest prices ever. Starting June 13, both self-cleaning roller mop robot vacuums are available for just $399.99, allowing shoppers to secure Prime Day pricing ahead of the broader promotional event.

The promotion marks a significant milestone for the category, bringing advanced self-cleaning roller mop technology into the sub-$400 segment and making one of the industry’s most sought-after cleaning innovations more accessible than ever before. As part of YEEDI’s “Less Time Cleaning. More Time Playing.” campaign, inspired by a summer of sports, family moments, and everyday adventures, the brand aims to help consumers spend less time on household chores and more time enjoying the moments that matter most. Complete offer details are available at YEEDI.com.

Bringing Premium Roller Mop Technology to More Homes

Roller mop technology has emerged as one of the most significant innovations in robotic floor cleaning, offering continuous scrubbing performance while automatically cleaning the mop during operation. However, robot vacuums equipped with self-cleaning roller systems have traditionally remained concentrated in premium price segments.

By bringing the M14 PLUS and S14 PLUS to $399.99, YEEDI is expanding access to one of the industry’s most advanced floor-cleaning technologies and establishing a new affordability benchmark for self-cleaning roller mop robot vacuums.

YEEDI M14 PLUS Reaches Its Lowest Price Ever

Available for $399.99 (regularly $599.99), the YEEDI M14 PLUS combines the brand’s OZMO Roller mopping technology with ZeroTangle anti-tangle technology to deliver powerful wet and dry cleaning while minimizing maintenance.

The robot is paired with an automated OMNI Station that handles dust collection, hot-water mop washing, and hot-air drying, reducing the need for manual upkeep. Designed for busy households seeking a hands-free cleaning experience, the M14 PLUS now offers premium functionality at an unprecedented value.

YEEDI S14 PLUS Delivers Flagship Cleaning at 67% Off

Available for $399.99 (regularly $1,199.99), the YEEDI S14 PLUS reaches its lowest price in history and represents one of the most compelling values in the premium robot vacuum category.

Winner of the CES 2025 Indoor Cleaning Technology Innovation Gold Award, the S14 PLUS combines YEEDI’s advanced OZMO Roller system and TruEdge 2.0 Adaptive Edge Cleaning technology for enhanced stain removal and edge-to-edge coverage.

Equipped with 18,000 Pa suction power and ZeroTangle 2.0 technology, the S14 PLUS delivers a flagship cleaning experience at a price point rarely seen in the premium robot vacuum market.

More Prime Day Deals Arrive June 23–26

Following the early access promotion, YEEDI will extend Prime Day deals across a broader selection of robot vacuums from June 23 through June 26, giving consumers even more opportunities to upgrade their home cleaning experience.

Featured offers include the YEEDI M16 Infinity at $449.99 (44% off), the YEEDI S20 Infinity at $699.99, the YEEDI S20 Infinity Ultra at $849.99, and the YEEDI S16 PLUS at $449.99. YEEDI will also introduce two new models: the M12 PRO Gen2 at an introductory price of $339.99 and the C14 PRO PLUS at $279.99.

Consumers can visit YEEDI.com to explore full Prime Day deals, and discover how YEEDI’s smart cleaning technology helps them spend less time cleaning and more time enjoying everyday life.

About YEEDI

YEEDI is a home cleaning technology brand dedicated to making advanced robotic vacuum technology practical, reliable, and accessible for everyday households. Guided by its philosophy of Accessible Innovation, YEEDI focuses on delivering powerful, user-friendly cleaning solutions that prioritize real-world usability, low maintenance, and long-term value.

View original content to download multimedia:https://www.prnewswire.com/news-releases/yeedi-delivers-lowest-ever-pricing-on-self-cleaning-roller-mop-robot-vacuums-with-early-prime-day-deals-302798950.html

SOURCE YEEDI Technology

Continue Reading

Trending